Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2021, Vol. 35 ›› Issue (1): 109-113.doi: 10.6040/j.issn.1673-3770.0.2020.037
Previous Articles Next Articles
YANG Yanyan, YANG YujuanOverview,SONG XichengGuidance
CLC Number:
[1] Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis[J]. Otolaryngol Head Neck Surg, 2015, 152(2): 197-206. doi: 10.1177/0194599814562166. [2] 王玮豪, 黄雪琨, 陈壮桂, 等. 广州地区变应性鼻炎与非变应性鼻炎临床特征的研究[J]. 中国耳鼻咽喉头颈外科, 2016, 23(9): 533-536. doi:10.16066/j.1672-7002.2016.09.011. WANG Weihao, HUANG Xuekun, CHEN Zhuanggui, et al. Clinical characteristics in patients with allergic rhinitis and nonallergic rhinitis in Guangzhou[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2016, 23(9): 533-536. doi:10.16066/j.1672-7002.2016.09.011. [3] Maio S, Baldacci S, Carrozzi L, et al. Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study[J]. Respir Med, 2016, 110: 58-65. doi:10.1016/j.rmed.2015.11.006. [4] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2015年,天津)[J].中华耳鼻咽喉头颈外科杂志, 2016, 51(1): 6-24. doi:10.3760/cma.j.issn.1673-0860.2016.01.004. [5] Meng YF, Wang CS, Zhang L. Recent developments and highlights in allergic rhinitis[J]. Allergy, 2019, 74(12): 2320-2328. doi:10.1111/all.14067. [6] Gu ZW, Wang YX, Cao ZW. Neutralization of interleukin-17 suppresses allergic rhinitis symptoms by downregulating Th2 and Th17 responses and upregulating the Treg response[J]. Oncotarget, 2017, 8(14): 22361-22369. doi:10.18632/oncotarget.15652. [7] Kuwabara T, Ishikawa F, Kondo M, et al. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases[J]. Mediators Inflamm, 2017, 2017(12): 1-11. doi:10.1155/2017/3908061. [8] Esser C, Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology[J]. Pharmacol Rev, 2015, 67(2): 259-279. doi:10.1124/pr.114.009001. [9] Wei P, Hu GH, Kang HY, et al. Increased aryl hydrocarbon receptor expression in patients with allergic rhinitis[J]. QJM, 2014, 107(2): 107-113. doi:10.1093/qjmed/hct188. [10] 卢汉桂, 林歆胜, 姚丹勉, 等. 变应性鼻炎大鼠IL-35的表达及对辅助性T细胞免疫调节的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 66-70. doi:10.6040/j.issn.1673-3770.0.2018.105. LU Hangui, LIN Xinsheng, YAO Danmian, et al. Expression of IL-35 in allergic rhinitis and its effect on the immunoregulation of T cells[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(5): 66-70. doi:10.6040/j.issn.1673-3770.0.2018.105. [11] Quintana FJ, Basso AS, Iglesias AH, et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor[J]. Nature, 2008, 453(7191): 65-71. doi:10.1038/nature06880. [12] Naufel AO, Aguiar MCF, Madeira FM, et al. Treg and Th17 cells in inflammatory periapical disease: a systematic review[J]. Braz Oral Res, 2017, 31: e103. doi:10.1590/1807-3107bor-2017.vol31.0103. [13] Ren J, Li B. The functional stability of FOXP3 and RORγt in treg and Th17 and their therapeutic applications[J]. Adv Protein Chem Struct Biol, 2017, 107: 155-189. doi:10.1016/bs.apcsb.2016.10.002. [14] Wei P, Hu GH, Kang HY, et al. An aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress the Th17 response in allergic rhinitis patients[J]. Lab Invest, 2014, 94(5): 528-535. doi:10.1038/labinvest.2014.8. [15] Ye J, Qiu J, Bostick JW, et al. The aryl hydrocarbon receptor preferentially marks and promotes gut regulatory T cells[J]. Cell Rep, 2017, 21(8): 2277-2290. doi:10.1016/j.celrep.2017.10.114. [16] 赵竞一,盖建青,闫新宇,等.鼻敏煎治疗变应性鼻炎及对Treg/Th17免疫平衡的影响[J]. 中国耳鼻咽喉头颈外科, 2018, 25(9): 44-49. doi: CNKI:SUN:EBYT.0.2018-09-012. ZHAO Jingyi, GAI Jianqing, YAN Xinyu, et al. Effect of Bimin Decoction on allergic rhinitis and immune balance of Th1/Th2 in lung qi weak and cold pattern patients[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2018, 25(9): 497-502. doi: CNKI:SUN:EBYT.0.2018-09-012. [17] 马娓, 黄文娟, 余静, 等. 芳香烃受体调控调节性T细胞的研究进展[J]. 中国细胞生物学学报, 2017, 39(1): 114-120. doi: 10.11844/cjcb.2017.01.0209. MA Wei, HUANG Wenjuan, YU Jing, et al. Progress of the role-aryl hydrocarbon receptor on regulatory T cell[J]. Chinese Journal of Cell Biology, 2017, 39(1): 114-120. doi: 10.11844/cjcb.2017.01.0209. [18] Abron JD, Singh NP, Mishra MK, et al. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis[J]. Am J Physiol Gastrointest Liver Physiol, 2018, 315(2): G220-G230. doi:10.1152/ajpgi.00413.2017. [19] Goettel JA, Gandhi R, Kenison JE, et al. AHR activation is protective against colitis driven by T cells in humanized mice[J]. Cell Rep, 2016, 17(5): 1318-1329. doi:10.1016/j.celrep.2016.09.082. [20] de Lima KA, Donate PB, Talbot J, et al. TGFβ1 signaling sustains aryl hydrocarbon receptor(AHR)expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism[J]. Cell Death Dis, 2018, 9(11): 1130. doi:10.1038/s41419-018-1107-7. [21] Ehrlich AK, Pennington JM, Bisson WH, et al. TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell Differentiation[J]. Toxicol Sci, 2018, 161(2): 310-320. doi:10.1093/toxsci/kfx215. [22] Schiering C, Wincent E, Metidji A, et al. Feedback control of AHR signalling regulates intestinal immunity[J]. Nature, 2017, 542(7640): 242-245. doi:10.1038/nature21080. [23] 霍娟, 杨晋, 胡文霞, 等. 类风湿关节炎患者外周血芳香烃受体表达与Th17细胞相关性研究[J]. 国际免疫学杂志, 2016, 39(5): 437-441. doi: 10.3760/cma.j.issn.1673-4394.2016.05.004. HUO Juan, YANG Jin, HU Wenxia, et al. Association of the expression of AhR in peripheral blood mononuclear cells and Th17 cell in the patients with rheumatoid arthritis[J]. International Journal of Immunology, 2016, 39(5): 437-441. doi: 10.3760/cma.j.issn.1673-4394.2016.05.004. [24] Lanis JM, Alexeev EE, Curtis VF, et al. Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia[J]. Mucosal Immunol, 2017, 10(5): 1133-1144. doi:10.1038/mi.2016.133. [25] Cheng L, Qian L, Tan Y, et al. Unbalanced expression of aryl hydrocarbon receptor in peripheral blood CCR6+CD4+ and CD4+CD25+T cells of rheumatoid arthritis[J]. Rev Bras Reumatol Engl Ed, 2017, 57(3): 190-196. doi:10.1016/j.rbre.2016.07.002. [26] Li XM, Peng J, Gu W, et al. TCDD-induced activation of aryl hydrocarbon receptor inhibits Th17 polarization and regulates non-eosinophilic airway inflammation in asthma[J]. PLoS One, 2016, 11(3): e0150551. doi:10.1371/journal.pone.0150551. [27] Yu HT, Jiang LL, Liu RQ, et al. Association between the ratio of aryl hydrocarbon receptor(AhR)in Th17 cells to AhR in Treg cells and SLE skin lesions[J]. Int Immunopharmacol, 2019, 69: 257-262. doi:10.1016/j.intimp.2019.01.039. [28] Al-Ghezi ZZ, Singh N, Mehrpouya-Bahrami P, et al. AhR activation by TCDD(2, 3, 7, 8-tetrachlorodibenzo-p-dioxin)attenuates pertussis toxin-induced inflammatory responses by differential regulation of tregs and Th17 cells through specific targeting by microRNA[J]. Front Microbiol, 2019, 10: 2349. doi:10.3389/fmicb.2019.02349. [29] Li XL, Cannon AR, Hammer AM, et al. IL-23 restoration of Th17 effector function is independent of IL-6 and TGF-β in a mouse model of alcohol and burn injury[J]. J Leukoc Biol, 2017, 102(3): 915-923. doi:10.1189/jlb.3A1216-527R. [30] Angelos MG, Ruh PN, Webber BR, et al. Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells[J]. Blood, 2017, 129(26): 3428-3439. doi:10.1182/blood-2016-07-730440. [31] 朱俊宇, 范霞, 梁华平. AhR调控炎性细胞因子的研究进展[J]. 免疫学杂志, 2017, 33(1): 73-77. doi: 10.1343/j.cnki.immunoi.j.20170014. ZHU Junyu, FAN Xia, LIANG Huaping. Research progress in regulation of aryl hydrocarbon receptor on inflammatory cytokines[J]. Immunological Journal, 2017, 33(1): 73-77. doi: 10.1343/j.cnki.immunoi.j.20170014. [32] Shi Q, Lei Z, Cheng G, et al. Mitochondrial ROS activate interleukin-1β expression in allergic rhinitis[J]. Oncol Lett, 2018, 16(3): 3193-3200. doi:10.3892/ol.2018.8984. [33] Li JP, Phadnis-Moghe AS, Crawford RB, et al. Aryl hydrocarbon receptor activation by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis[J]. Toxicology, 2017, 378: 17-24. doi:10.1016/j.tox.2016.12.010. [34] Dolciami D, Gargaro M, Cerra B, et al. Binding mode and structure-activity relationships of ITE as an aryl hydrocarbon receptor(AhR)agonist[J]. Chem Med Chem, 2018, 13(3): 270-279. doi:10.1002/cmdc.201700669. [35] Zhu JY, Luo L, Tian LX, et al. Aryl hydrocarbon receptor promotes IL-10 expression in inflammatory macrophages through src-STAT3 signaling pathway[J]. Front Immunol, 2018, 9: 2033. doi:10.3389/fimmu.2018.02033. [36] Yu SQ, Jin L, Che N, et al. Dendritic cells modified with Der p1 antigen as a therapeutic potential for allergic rhinitis in a murine model via regulatory effects on IL-4, IL-10 and IL-13[J]. Int Immunopharmacol, 2019, 70: 216-224. doi:10.1016/j.intimp.2019.02.045. [37] Tsuji G, Hashimoto-Hachiya A, Kiyomatsu-Oda M, et al. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis[J]. Cell Death Dis, 2017, 8(7): e2931. doi:10.1038/cddis.2017.322. [38] Mohinta S, Kannan AK, Gowda K, et al. Differential regulation of Th17 and T regulatory cell differentiation by aryl hydrocarbon receptor dependent xenobiotic response element dependent and independent pathways[J]. Toxicol Sci, 2015, 145(2): 233-243. doi:10.1093/toxsci/kfv046. |
[1] | NI Jingzi, WAN Wenjin,CHENG Lei. Research progress on health-related quality of life in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 110-115. |
[2] | LIN Yihang,LI Youjin. Research progress on gut microbiome in children with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 116-122. |
[3] | LIU Zhen,SONG Xicheng. Mechanisms and research progress of pyroptosis in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 123-129. |
[4] | LIU Yitong, ZHOU Suizi,QIU Qianhui. Research progress on NLRP3 inflammasome in chronic rhinosinusitis and allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 142-146. |
[5] | GONG Xiaoyang, CHENG Lei. Analysis of proportion of outpatients with allergic rhinitis during the coronavirus infectious disease 2019 pandemic [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 245-255. |
[6] | ZHANG Yaqi, LIU Huimin, CAO Linman, WANG Ziyu, LIN Xu, LI Yanping, XUE Gang, WU Jingfang. Expression and significance of the MAPK,PI3K-AKT,NF-κB pathways of allergic rhinitis in mice [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 254-259. |
[7] | LU Weili, JIANG Tao, LI Xianhua. Analysis of sIgE in polysensitized children with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 260-265. |
[8] | HUANG Kaiyue, LI Xueqing, HAN Gouxin, ZHANG Qinxiu. Meta-analysis of acupoint catgut embedding in the treatment of allergic rhinitis based on the theory of “lung and spleen” [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 266-274. |
[9] | ZHU Zhengru, ZHANG Xiaobing. Meta-analysis of the curative effect of traditional Chinese medicine decoction combined with conventional western medicine on allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 281-289. |
[10] | PANG Chong, BIAN Sainan, ZHANG Bing, YIN Xu, LU Yingxia, YE Pengfei, WANG Zhan, ZHAO Jing, GAO Yan, GUAN Kai. Short-term effect of Dermatophagoides farinae specific sublingual immunotherapy for children with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 70-74. |
[11] | WANG Fei, LIU Yuying, XIAO Qiyi, DING Jian, GAO Shang, MAO Wei. A study on the associations between psychological factors and allergic rhinitis among residents [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 28-31. |
[12] | WANG Xin, LIU Qiaoping, YAN Zhanfeng, LIU Siming, ZHU Yajing, DING Qian, ZHANG Ying, TIAN Yuan, ZHANG Jingran. A study on the mechanism of action of the Xiaoqinglong Decoction in treating allergic rhinitis based on network pharmacology [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 46-55. |
[13] | WANG Yuting,,WANG Jiaxi. Research developments on microRNA in the pathogenesis of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 98-104. |
[14] | LI Huajing, HAO Runmei, DAI Hao, ZHANG Ling, SHEN Zhen, QUAN Fang, SHAO Yuan. Mechanism of inhibition of ovalbumin-induced inflammation by catechins in an OVA-induced mouse model of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 1-7. |
[15] | LIN Xiaoyan, LI Jing, MA Zhiqi, LI Yilin, GAO Xinyi, LI Yong. Therapeutic and anti-allergic effects of probiotics on allergic rhinitis: a meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(3): 70-80. |
|